These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 21375989)

  • 1. [Hepatitis C virus infection and human genetics].
    Benfield T; Clausen LN
    Ugeskr Laeger; 2011 Mar; 173(10):730. PubMed ID: 21375989
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.
    Tang J; Kaslow RA
    Pharmacogenomics J; 2004; 4(3):171-4. PubMed ID: 15069460
    [No Abstract]   [Full Text] [Related]  

  • 3. Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b.
    Iwasa M; Kaito M; Ikoma J; Takeo M; Imoto I; Adachi Y; Yamauchi K; Koizumi R; Teraguchi S
    Am J Gastroenterol; 2002 Mar; 97(3):766-7. PubMed ID: 11922584
    [No Abstract]   [Full Text] [Related]  

  • 4. Apolipoprotein E4 allele is associated with poor treatment response in hepatitis C virus (HCV) genotype 1.
    Mueller T; Gessner R; Sarrazin C; Graf C; Halangk J; Witt H; Köttgen E; Wiedenmann B; Berg T
    Hepatology; 2003 Dec; 38(6):1592; author reply 1592-3. PubMed ID: 14647071
    [No Abstract]   [Full Text] [Related]  

  • 5. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission.
    Zampino R; Marrone A; Karayiannis P; Cirillo G; del Giudice EM; Rania G; Utili R; Ruggiero G
    Am J Gastroenterol; 2002 Sep; 97(9):2426-31. PubMed ID: 12358268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
    Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
    Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C virus infection in children.
    Mohan N; González-Peralta RP; Fujisawa T; Chang MH; Heller S; Jara P; Kelly D; Mieli-Vergani G; Shah U; Murray KF
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):123-31. PubMed ID: 20038846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial spontaneous clearance and re-infection with a distinct hepatitis C virus genotype leading to chronic hepatitis C in an HIV+ intravenous drug user.
    Vispo E; Martinez-Alarcon J; Poveda E; Toro C; Soriano V
    AIDS; 2008 Jan; 22(2):318. PubMed ID: 18097239
    [No Abstract]   [Full Text] [Related]  

  • 10. Telaprevir: a new hope in the treatment of chronic hepatitis C?
    Fowell AJ; Nash KL
    Adv Ther; 2010 Aug; 27(8):512-22. PubMed ID: 20652658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quasispecies nature of hepatitis C virus (HCV) in patients with chronic hepatitis C with mixed HCV subtypes.
    Toyoda H; Fukuda Y; Nakano I; Katano Y; Takayama T; Kumada T; Nakano S; Takamatsu J; Saito H; Hayakawa T
    J Med Virol; 1998 Feb; 54(2):80-5. PubMed ID: 9496363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
    Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive hepatitis C virus RNA detection assays for decision of treatment (dis)continuation in patients with chronic hepatitis C.
    Mihm U; Hofmann WP; Kronenberger B; Wagner Mv; Zeuzem S; Sarrazin C
    J Hepatol; 2005 Apr; 42(4):605-6. PubMed ID: 15763349
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
    Nakamura H; Ogawa H; Kuroda T; Yamamoto M; Enomoto H; Kishima Y; Yoshida K; Ito H; Matsuda M; Noguchi S
    Hepatogastroenterology; 2002; 49(47):1373-6. PubMed ID: 12239945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes.
    Chevaliez S; Pawlotsky JM
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1031-48. PubMed ID: 19187865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: should we utilize more?
    Aghemo A; Rumi MG; Prati GM; Colombo M
    Hepatology; 2009 Feb; 49(2):702-3; author reply 703-4. PubMed ID: 19177585
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection.
    Yoshioka K; Ito H; Watanabe K; Yano M; Ishigami M; Mizutani T; Sasaki Y; Goto H
    J Viral Hepat; 2005 Mar; 12(2):139-45. PubMed ID: 15720528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in hepatitis C virus infection routes and genotype distribution in a Lithuanian cohort with chronic hepatitis C.
    Liakina V; Speiciene D; Irnius A; Valantinas J
    Med Sci Monit; 2009 Apr; 15(4):PH17-23. PubMed ID: 19333213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune thrombocytopenic purpura in patients with hepatitis C virus infection.
    Nakajima H; Takagi H; Yamazaki Y; Toyoda M; Takezawa J; Nagamine T; Mori M
    Hepatogastroenterology; 2005; 52(64):1197-200. PubMed ID: 16001660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.